IDH1 and glioblastoma: We investigated the proteogenomic reflection of the M17-H signature using transcriptomic and mass spectroscopy-based proteomic data from matched samples of GBM patients (CPTAC GBM database, N = 86 after filtering out IDH-mutated and/or poor-quality samples based on pathology assessment)53.